We are enclosing herewith trasncript of earning conference call held on May12, 2025, wherein Audited standalone & Consolidated Financial result for the 2nd half year ended March 31, 2025 (FY2025) were discussed. The said transcript is also available in the investor senction of our website.
Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), the audio recording of the Conference call held today i.e. on Wednesday, May 14, 2025 on the audited Financial Results for the quarter and year ended March 31, 2025, is available on the website of the Company at www.advancedenzymes.com/investors/analyst-corner
